THE MECHANISM OF REDUCTION OF TOXIC CHEMICALS AND DRUGS
减少有毒化学品和药物的机制
基本信息
- 批准号:3841111
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
The first step in the metabolic conversion of many chemicals and toxic
drugs is the reduction of the parent compound to give a free radical
intermediate. This metabolism has been shown to occur in both liver
microsomes and hepatocytes. For nitroheterocyclic drugs, the nitro group
is reduced to the corresponding nitro radical anion and for bipyridylium
dictations, the parent compound is reduced to the bipyridylium radical
monocation. By judicious application of paramagnetic line broadening
agents, we have shown that the radicals, initially formed inside the cell
can freely cross the plasma membrane, and the EPR signal detected is mainly
due to radical present extracellularly. Recently, the laboratory purchased
a Krumdieck tissue slicer. This type of slicer has been shown to produce
reproducibly thin slices with maximal slice integrity. Liver slices,
unlike microsomes or hepatocytes, contain a cross section of all liver
cells and the results are more physiologically similar to in vivo liver
metabolism. This is the first such EPR application to organ slices which
has not been lyophilized or encased in paraffin supports. Preliminary
experiments with bipyridylium dictations have shown that it is possible to
detect free radical intermediates in thin liver slices and that the radical
generated is in a more viscous environment than with either microsomes or
hepatocytes. In the coming year, we will continue this line of
investigation and extend the experiments to include nitroheterocyclic
compounds.
代谢的第一步是将许多化学物质转化为有毒物质
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
R P MASON其他文献
R P MASON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('R P MASON', 18)}}的其他基金
PHENYL RADICAL FORMATION BY OXYHEMOGLOBIN FROM PHENYLHYDRAZINE IN VIVO
体内苯肼的氧合血红蛋白形成苯基自由基
- 批准号:
3918695 - 财政年份:
- 资助金额:
-- - 项目类别:
RELATIONSHIP OF FREE RADICALS TO HALOCARBON-INDUCED TOXICITY IN THE LIVER
自由基与卤代烃引起的肝脏毒性的关系
- 批准号:
3918692 - 财政年份:
- 资助金额:
-- - 项目类别:
RELATIONSHIP OF FREE RADICALS TO HALOCARBON-INDUCED TOXICITY IN THE LIVER
自由基与卤代烃引起的肝脏毒性的关系
- 批准号:
3876930 - 财政年份:
- 资助金额:
-- - 项目类别:
OXIDATION OF AGRANULOCYTOSIS CAUSING DRUGS BY MYELOPEROXIDASE
髓过氧化物酶对引起粒细胞增多症的药物的氧化
- 批准号:
3755463 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Elucidation of endoplasmic reticulum transporters in drug metabolism
阐明药物代谢中的内质网转运蛋白
- 批准号:
23H02648 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (B)
2023 Drug Metabolism Gordon Research Conference and Gordon Research Seminar
2023年药物代谢戈登研究会议暨戈登研究研讨会
- 批准号:
10751553 - 财政年份:2023
- 资助金额:
-- - 项目类别:
In vitro assessment of kratom pharmacokinetic CYP interactions with HIV ART drug metabolism
卡痛叶药代动力学 CYP 与 HIV ART 药物代谢相互作用的体外评估
- 批准号:
10746628 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Hormone mediated mechanisms of altered drug metabolism and transport in transgender adults
跨性别成人药物代谢和转运改变的激素介导机制
- 批准号:
10506038 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Mechanism Of Enterococcus Faecalis Nitro Drug Metabolism And In Vivo Implications
粪肠球菌硝基药物代谢机制及其体内影响
- 批准号:
10511022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Development of a drug metabolism capacity and interaction evaluation system for the elderly with sarcopenia and avoidance of adverse drug reaction risks.
建立老年人肌少症药物代谢能力及相互作用评价体系,避免药物不良反应风险。
- 批准号:
22K06763 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Comprehensive pathway generation of drug action and drug metabolism for DrugBank
DrugBank 药物作用和药物代谢的综合路径生成
- 批准号:
565707-2021 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Alliance Grants
Computational prediction of gut microbiome-mediated drug metabolism
肠道微生物介导的药物代谢的计算预测
- 批准号:
10558540 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Inter-Enzyme Crosstalk in the Cytochrome P450 Ensemble: Implications for the Effects of Alcohol on Drug Metabolism and Alcohol-Drug Interactions
细胞色素 P450 整体中的酶间串扰:酒精对药物代谢和酒精-药物相互作用影响的影响
- 批准号:
10704053 - 财政年份:2022
- 资助金额:
-- - 项目类别:
SUBJECT MATTER EXPERT CONSULTANT FOR DRUG METABOLISM PHARMACOKINETICS [DMPK].
药物代谢药代动力学 [DMPK] 主题专家顾问。
- 批准号:
10721124 - 财政年份:2022
- 资助金额:
-- - 项目类别: